Area of research
Oncology · Hematology
Research interest
Research focused on Adverse Event Reporting System and Autologous stem-cell transplantation, with related work in Rituximab, Adverse effect, Hematology. Notable publications include 'Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma', 'Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers', and 'Cardiovascular toxicities associated with bispecific T-cell engager therapy'.
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment—USMIRC Group
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies
Cardiovascular toxicities associated with bispecific T-cell engager therapy
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 <scp>U.S.</scp> cancer centers
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma